TrianglePUBLICATIONS · 28182116
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Onco Targets Ther
- Publication date
- 2017
- First author
- Váradi Z
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Váradi Z
- type
- Author
- name
- Bánusz R
- type
- Author
- name
- Csomor J
- type
- Author
- name
- Kállay K
- type
- Author
- name
- Varga E
- type
- Author
- name
- Kertész G
- type
- Author
- name
- Csóka M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Váradi Z
- type
- Author
- name
- Bánusz R
- type
- Author
- name
- Csomor J
- type
- Author
- name
- Kállay K
- type
- Author
- name
- Varga E
- type
- Author
- name
- Kertész G
- type
- Author
- name
- Csóka M
- type
- Author
- bibliography ids
- nci-bib-d07f11702acc7181b833832d
- book metadata
- content sha256
- 76a761aaff2324ac518a618f81262f1c90c38dfc633bb1f115b58b60cae3168c
- document type
- citation
- dois
- 10.2147/OTT.S121615
- electronic publication date
- display
- 2017 Jan 24
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28182116
- immutable id
- pubmed:28182116@76a761aaff2324ac518a618f81262f1c90c38dfc633bb1f115b58b60cae3168c
- journal
- abbreviation
- Onco Targets Ther
- issn electronic
- 1178-6930
- issn print
- 1178-6930
- issue
- Source null
- name
- OncoTargets and therapy
- nlm unique id
- 101514322
- pages
- 521-526
- volume
- 10
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28182116
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 5d6a866db8334b4094ea805dc4a54db6f0b5e9b541eb6e6a4f8cc62f37b7f836
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017
- precision
- year
- year
- 2017
- publication types
- Case Reports
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Preserved source evidence · Independent clinical review pending · Not medical advice